Throughout the last year, we saw movements in all industries when it came to the ever-changing legal recruitment market, especially within the Life Sciences space which, in this environment, is more important than ever. Our team, who exclusively focus on the Legal Life Sciences market had had to adapt, like many others, to a new way of working and ensure we continue to supp...

The global health crisis caused by Covid-19 resulted in many becoming accustomed to spending far more time at home than usual. With the days blending seamlessly into the next, how have individuals made productive use of this time during local lockdowns and periods of self-isolation? Some utilized this new-found time to prioritize self-care, rediscover a particular passion, o...

​More than 90% of CEOs report that diversity is a top business priority, yet the dial towards progress has moved forward slowly in recent years. With diversity and inclusion at the top of the agenda, we explore the current state of affairs for women in color in life sciences and the underlying processes within recruitment that may create obstacles to increasing their represe...

The importance of utilizing value-based research within the healthcare industry to inform decisions on the patient population has increased tremendously since COVID-19 forced us into lockdown. Pharmaceutical companies in the past have relied heavily on data compiled by epidemiologists to forecast which products will have a lasting impact on their consumers’ base. However, d...

Commercial Pharma Trends for the New Year The push for multi-channel marketing tactics by pharmaceutical companies has increased drastically since the pandemic-induced lockdown affected our day-to-day lives. Pharmaceutical companies have traditionally relied on salespeople and Medical Science Liaison’s (MSL’s) for one-on-one conversations with physicians and other clients. ...

​We are at a crossroads. The health and wellbeing of the workforce has never been more closely intertwined with the state of the economy.The public health crisis caused by Covid-19 has forced operational change and reflection on the way that people organize and work. Global lockdowns have meant that many companies have shifted to remote working – where they are able to – res...

In this complex social and economic climate, it can be hard to understand how current and prospective employees are feeling and thinking. Thanks to our expansive network, we are able to gauge the sentiment and aspirations of the life sciences workforce in the United States, and share that vital information with you. The EPM Scientific Job Confidence Index 2020 is a new annua...

​When workers finally return to the office, the life sciences workplace will be virtually unrecognizable. What short and lasting impact will the pandemic have on the workplace? How will these changes affect talent? What does this guide explore?Short term impactRedesigning the workplace for human healthNegative and positive impacts of social distancingRisk assessment and priv...

​What role can recruitment play in creating a gender-balanced workforce throughout the life sciences industry? Thomas Hellen, Principal Consultant for EPM Scientific, shares his thoughts for International Women's Day 2020.The 2020 International Women’s Day theme is that an equal world is an enabled world. What does that mean to you in life sciences?Women in healthcare curren...

What role can recruitment play in creating a gender-balanced workforce throughout the life sciences industry? Micaela Siegel, Principal Consultant at EPM Scientific, shares her thoughts for International Women's Day 2020.The 2020 International Women’s Day theme is that an equal world is an enabled world. What does that mean to you in life sciences?An equal and enabled world ...

Our modern way of life is the cause and the cure to the organ transplantation crisis. Technological advancements and increasing wealth have led to a booming population that suffers chronic illness, obesity and old age. These factors contribute to a massive demand for organs that outstrips supply. In the US alone, over 120,000 people are currently on the transplantation waiti...

​​90% of CEOs report that diversity is a top business priority, yet the dial towards progress has hardly moved in recent years. A quantitative study by MassBio showed that although women make up half of the entry-level positions in biotech, they fill only 20 percent of senior leadership slots and 10 percent of board seats. While a 2017 study of the US biotech industry by Nat...

​We are delighted to announce Andrew McNeilis, Chief Commercial Officer, will be moderating a panel this year at Boston BD, taking place on September 10th, 2019. This forum convenes C-level executives to discuss the most pressing business development challenges and opportunities facing the biopharma industry. This conference is a part of Biotech Week Boston, a festival of in...

​For many emerging US-based biotech companies, taking their first product to Europe is a daunting prospect. Directly launching abroad is a difficult path, with many companies deciding to out-license rights for that territory instead. While doing so cuts down risk, it typically reduces profits and inhibits the potential to create a global brand and market strategy; companies ...

​Biotech start-ups can be nimble and responsive if they utilize a small, tight-knit, interdisciplinary team. However, the minute work-groups start to expand they are susceptible to the founder’s dilemma. So how can an elite team find the right recruits that will align in terms of their technical skills, experience and vision, as well as their cultural fit? Small teams can be...

In the last decade, innovations in cell and gene-based therapies have changed the Oncology recruitment market. So what does a top Oncology candidate look like in 2019?In the lead-up to the American Society of Clinical Oncology (ASCO) annual conference, we always take stock of current trends in Oncology recruitment. In 2019 new therapies, like gene editing, are driving the ma...

​Up to 77% of biotech and pharma outsource portions of their analytics or production. There are many reasons to outsource, in source, or stay completely in-house. For biometrics teams, outsourcing can increase standardization while staying in-house decreases turnaround time.Biotech and pharma often debate whether to outsource analytics. Benefits of outsourcing can include re...

​In the past, biotech startups have sought to partner with big pharmaceutical companies.  However, the market is changing — in 2019 it may be better to license directly in Europe.For a US-based pharmaceutical company, the prospect of taking a new drug to market in Europe can be daunting.  Many young biotech companies decide to out-license for royalty or milestone payments in...

​UCSFs bioartificial kidney is an exciting breakthrough which circumvents the need for tissue-blood supply, using  cyborg-like silicon chips. In this article we explore UCSF’s Kidney Project, the latest applications of tissue engineering, and the recruitment trends within the pharma and biotech fields.We have previously discussed how the fields of tissue-engineering and rege...

​Tissue-engineered substrates like Axogen nerve-grafts and 3D-printed hydrogels have penetrated past the hype phase of the Garner hype cycle to the main market.  Tissue-engineering and regenerative medicine are hot topics lately.  While the average person associates these therapies with idealistic sci-fi, the truth is that these therapies have exited controversial trial-and-...